EP300 and cancer: To better characterize the degree of sensitivity displayed by CDS cells toward p300 inhibition, we took advantage of a study reporting the effect of A-485 on 124 different cancer cell lines treated with this compound for 3, 4, and 5 days, and where the sensitivity threshold was set at 1μM or below [24].